TAIWAN · TWSE / TPEx
FCB
豐技生技 · 6744 · Emerging Stock Board · Biotech and medical
Share price, 2026-10-16NT$14.451 month -3.3% · 1 year -24.9%
Directors and supervisors hold7,639,52449.6% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold6,533,52742.4% of shares issued
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 張宏名 | Chairman · President | 566,168 | 566,168 | 3.68% | — | — |
| 列特博生技股份有限公司 | Director · Major shareholder (10%+) | 4,242,428 | 4,242,428 | 27.55% | — | — |
| 戴極昇 | Director (corporate representative) | — | 122,000 | 0.79% | — | — |
| 浙江博聖生物技術股份有限公司 | Director · Major shareholder (10%+) | 2,291,099 | 2,291,099 | 14.88% | — | — |
| 張民 | Director (corporate representative) | — | 0 | — | — | — |
| 呂美珍 | Director · Chief financial officer · Chief accountant | 539,829 | 539,829 | 3.51% | — | — |
| 劉助 | Independent director | — | 0 | — | — | — |
| 陳柏年 | Independent director | — | 0 | — | — | — |
| 洪建龍 | Independent director | — | 0 | — | — | — |
| 林佩宜 | Vice president | — | 182,460 | 1.18% | — | — |
| 張書銘 | Vice president | — | 0 | — | — | — |
| 劉冠良 | Manager | — | 0 | — | — | — |
| 張智凱 | Manager | — | 3,000 | 0.02% | — | — |
| 張逢顯 | Manager | — | 2,000 | 0.01% | — | — |
| 張耀仁 | Other | — | 0 | — | — | — |